Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies. [PDF]
Douxfils J +3 more
europepmc +1 more source
The Fruits of Conservatism in the Treatment of Ovarian Pathology [PDF]
Christian, Howard J.
core +1 more source
Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population-Based Study. [PDF]
Nilsson S +5 more
europepmc +1 more source
No more sleepless nights in perimenopause-an open-label, randomized, parallel-group, active controlled intervention study in perimenopausal women with vasomotor symptoms and insomnia to investigate the efficacy of hormone replacement therapy and cognitive behavioral therapy for the treatment of insomnia: study protocol. [PDF]
Pavicic E +4 more
europepmc +1 more source
Can cognitive behavioral therapy improve vasomotor symptoms and recurrent depression in postmenopausal women? [PDF]
Tamashiro LAD +6 more
europepmc +1 more source
Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey: Erratum. [PDF]
Todorova L +7 more
europepmc +1 more source
Fezolinetant for moderate to severe vasomotor symptoms associated with menopause. [PDF]
europepmc +1 more source
Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause. [PDF]
Trigg A +8 more
europepmc +1 more source
A Systematic Review of Anxiety and Depressive Symptoms Among Women Experiencing Vasomotor Symptoms Across Reproductive Stages in the US. [PDF]
Gibson CJ +7 more
europepmc +1 more source

